These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 28942563)

  • 1. Polypharmacy in the Geriatric Oncology Population.
    Hersh LR; Beldowski K; Hajjar ER
    Curr Oncol Rep; 2017 Sep; 19(11):73. PubMed ID: 28942563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypharmacy and potentially inappropriate medication use in geriatric oncology.
    Sharma M; Loh KP; Nightingale G; Mohile SG; Holmes HM
    J Geriatr Oncol; 2016 Sep; 7(5):346-53. PubMed ID: 27498305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Drug Reactions in an Oncological Population: Prevalence, Predictability, and Preventability.
    Lavan AH; O'Mahony D; Buckley M; O'Mahony D; Gallagher P
    Oncologist; 2019 Sep; 24(9):e968-e977. PubMed ID: 30833488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Polypharmacy on Patient Outcomes in Older Adults With Cancer.
    Nightingale G; Skonecki E; Boparai MK
    Cancer J; 2017; 23(4):211-218. PubMed ID: 28731943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Risk of Polypharmacy Among Elderly Cancer Patients Receiving Chemotherapy in Ambulatory Oncology Setting.
    Goh I; Lai O; Chew L
    Curr Oncol Rep; 2018 Mar; 20(5):38. PubMed ID: 29582192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Look at Polypharmacy and Medication Screening Tools for the Older Cancer Patient.
    Whitman AM; DeGregory KA; Morris AL; Ramsdale EE
    Oncologist; 2016 Jun; 21(6):723-30. PubMed ID: 27151653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Geriatric oncology: an emergent subspecialty].
    Freyer G; Falandry C
    Rev Med Interne; 2013 Oct; 34(10):589-90. PubMed ID: 23694957
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence, severity, and nature of risk factors associated with drug-drug interactions in geriatric patients receiving cancer chemotherapy: A prospective study in a tertiary care teaching hospital.
    Ramasubbu SK; Mahato SK; Agnihotri A; Pasricha RK; Nath UK; Das B
    Cancer Treat Res Commun; 2021; 26():100277. PubMed ID: 33348276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions in special populations - the elderly.
    Davies EA; O'Mahony MS
    Br J Clin Pharmacol; 2015 Oct; 80(4):796-807. PubMed ID: 25619317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is my older cancer patient on too many medications?
    Turner JP; Shakib S; Bell JS
    J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
    Sokol KC; Knudsen JF; Li MM
    J Clin Pharm Ther; 2007 Apr; 32(2):169-75. PubMed ID: 17381667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Audit of drug-drug interactions and adverse drug reactions due to polypharmacy in older cancer patients: First report from India.
    Paul T; Palatty PL; Adnan M; George T; Rao S; Baliga MS
    Indian J Cancer; 2020; 57(4):405-410. PubMed ID: 33078746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Adverse Drug Reactions in Older Subjects Hospitalized in a Dedicated Dementia Unit.
    Kanagaratnam L; Dramé M; Novella JL; Trenque T; Joachim C; Nazeyrollas P; Jolly D; Mahmoudi R
    Am J Geriatr Psychiatry; 2017 Mar; 25(3):290-296. PubMed ID: 27742527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit.
    Flood KL; Carroll MB; Le CV; Brown CJ
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):151-8. PubMed ID: 19616183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Practical Guide to Geriatric Syndromes in Older Adults With Cancer: A Focus on Falls, Cognition, Polypharmacy, and Depression.
    Magnuson A; Sattar S; Nightingale G; Saracino R; Skonecki E; Trevino KM
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e96-e109. PubMed ID: 31099668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of pre-operative medication use with post-surgery mortality and morbidity in oncology patients receiving comprehensive geriatric assessment.
    Choi KS; Jeong YM; Lee E; Kim KI; Yee J; Lee BK; Chung JE; Rhie SJ; Gwak HS
    Aging Clin Exp Res; 2018 Oct; 30(10):1177-1185. PubMed ID: 29411331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse drug reactions in older adults: a narrative review of the literature.
    Zazzara MB; Palmer K; Vetrano DL; Carfì A; Onder G
    Eur Geriatr Med; 2021 Jun; 12(3):463-473. PubMed ID: 33738772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underprescription of medications in older adults: causes, consequences and solutions-a narrative review.
    Lombardi F; Paoletti L; Carrieri B; Dell'Aquila G; Fedecostante M; Di Muzio M; Corsonello A; Lattanzio F; Cherubini A
    Eur Geriatr Med; 2021 Jun; 12(3):453-462. PubMed ID: 33709336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy: the challenge for nurses.
    Kaufman G
    Nurs Stand; 2016 May; 30(39):52-60. PubMed ID: 27224631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rules for improving pharmacotherapy in older adult patients: part 1 (rules 1-5).
    Wooten JM
    South Med J; 2015 Feb; 108(2):97-104. PubMed ID: 25688894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.